-
21.Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof 失效
Title translation: 衍生自恶唑烷-2-酮的化合物及其制备和治疗用途公开(公告)号:US5925662A
公开(公告)日:1999-07-20
申请号:US66364
申请日:1998-05-08
Applicant: Samir Jegham , Frederic Puech , Philippe Burnier , Danielle Berthon
Inventor: Samir Jegham , Frederic Puech , Philippe Burnier , Danielle Berthon
IPC: A61K31/00 , A61K31/42 , A61K31/422 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , C07D413/04
CPC classification number: C07D413/04
Abstract: Derivatives of oxazolidin-2-one of general formula (I) ##STR1## in which: n is equal to 0 or 1,R.sub.1 represents a cyano group, an alkyl group or a fluoroalkyl group,R.sub.2 represents a hydrogen atom or a hydroxyl group, andR.sub.3 represents a hydrogen atom or a methyl group.Application in therapeutics.
Abstract translation: PCT No.PCT / FR96 / 01732 Sec。 371日期1998年5月8日 102(e)日期1998年5月8日PCT 1996年11月5日PCT PCT。 公开号WO97 / 17347 日期:1997年5月15日通式(I)的恶唑烷-2-酮的衍生物,其中:n等于0或1,R1表示氰基,烷基或氟代烷基,R2表示氢原子或羟基 基团,R 3表示氢原子或甲基。 在治疗中的应用。
-
22.N-[(1,4-diazabicyclo[2.2.2] oct-2-yl)methyl] benzamide derivatives, their preparations and their application in therapeutics 失效
Title translation: N - [(1,4-二氮杂双环[2.2.2]辛-2-基)甲基]苯甲酰胺衍生物,其制备及其在治疗中的应用公开(公告)号:US5663173A
公开(公告)日:1997-09-02
申请号:US662199
申请日:1996-06-12
Applicant: Samir Jegham , Jean Jacques Koenig , Alistair Lochead , Alain Nedelec , Yves Guminski
Inventor: Samir Jegham , Jean Jacques Koenig , Alistair Lochead , Alain Nedelec , Yves Guminski
IPC: A61K31/495 , A61P1/00 , A61P9/00 , A61P13/02 , A61P15/00 , A61P25/00 , A61P43/00 , C07D487/08 , C02D487/08
CPC classification number: C07D487/08
Abstract: An optically active isomer or a racemate of a compound of general formula (I) ##STR1## in which either R.sub.1 represents a methoxy or cyclopropylmethoxy group andR.sub.2 represents a hydrogen, chlorine or bromine atom, orR.sub.1 and R.sub.2 together form, and in this order, a group of formula --O--CH.sub.2 --O--, --O--(CH.sub.2).sub.2 --, --O--(CH.sub.2).sub.2 --O-- or --O--(CH.sub.2).sub.3 --O--,R.sub.3 represents a hydrogen atom or an amino group, andR.sub.4 represents a hydrogen, chlorine or bromine atom,in the form of a free base or of a pharmaceutically acceptable acid addition salt.
Abstract translation: 通式(I)化合物(I)的光学活性异构体或外消旋物,其中R 1表示甲氧基或环丙基甲氧基,R 2表示氢,氯或溴原子,或者R 1和R 2一起形成, 并且按此顺序,式-O-CH2-O-,-O-(CH2)2-,-O-(CH2)2-O-或-O-(CH2)3-O-,R3表示 氢原子或氨基,R 4表示氢,氯或溴原子,以游离碱或药学上可接受的酸加成盐的形式存在。
-
23.ANTICANCER DERIVIATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF 审中-公开
Title translation: 反应物衍生物,其制备方法及其治疗方法公开(公告)号:US20120094986A1
公开(公告)日:2012-04-19
申请号:US13258847
申请日:2010-03-22
Applicant: Jérôme Arigon , Claude Bernhart , Monsif Bouaboula , Romain Combet , Sandrine Hilairet , Samir Jegham
Inventor: Jérôme Arigon , Claude Bernhart , Monsif Bouaboula , Romain Combet , Sandrine Hilairet , Samir Jegham
IPC: A61K31/444 , C07D417/14 , A61P35/00 , C07D401/14 , A61K31/4545 , C07D401/12 , A61K31/541
CPC classification number: C07D213/82 , C07D417/14
Abstract: The invention relates to nicotinamide derivatives which can be used as anticancer drugs.
Abstract translation: 本发明涉及可用作抗癌药物的烟酰胺衍生物。
-
24.NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS ANTICANCER DRUGS 审中-公开
Title translation: 尼古丁衍生物,其制剂及其作为抗感染药物的治疗用途公开(公告)号:US20120053170A1
公开(公告)日:2012-03-01
申请号:US13258220
申请日:2010-03-22
Applicant: Jérome Arigon , Claude Bernhart , Monsif Bouaboula , Romain Combet , Sandrine Hilairet , Samir Jegham
Inventor: Jérome Arigon , Claude Bernhart , Monsif Bouaboula , Romain Combet , Sandrine Hilairet , Samir Jegham
IPC: A61K31/55 , C07D417/14 , C07D401/12 , C07F5/02 , C07F5/04 , C07D239/42 , C07D213/82 , C07D239/30 , A61K31/4545 , A61K31/506 , A61K31/541 , A61K31/444 , A61K31/496 , A61P35/00 , C07D401/14
CPC classification number: C07D401/12 , C07D213/79 , C07D213/82 , C07D239/42 , C07D401/14 , C07D417/12
Abstract: The present invention relates to nicotinamide derivatives of formula (I), to compositions containing same, and to the therapeutic use thereof, in particular as anticancer drugs. The invention also relates to the method for preparing said compounds, as well as to some of the intermediate products.
Abstract translation: 本发明涉及式(I)的烟酰胺衍生物,含有其的组合物及其治疗用途,特别是作为抗癌药物。 本发明还涉及制备所述化合物的方法以及一些中间产物。
-
25.ANTINEOPLASTIC DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF 审中-公开
Title translation: 抗生素衍生物,其制备方法及其治疗方法公开(公告)号:US20110251194A1
公开(公告)日:2011-10-13
申请号:US12986642
申请日:2011-01-07
Applicant: Claude BERNHART , Gary MCCORT , Samir JEGHAM , Jean Marc HERBERT , Pierre CASELLAS , Monsif BOUABOULA , Olivier DUCLOS
Inventor: Claude BERNHART , Gary MCCORT , Samir JEGHAM , Jean Marc HERBERT , Pierre CASELLAS , Monsif BOUABOULA , Olivier DUCLOS
IPC: A61K31/496 , C07D401/02 , A61K31/5377 , A61K31/4709 , A61P35/00 , C07D471/04 , A61K31/444
CPC classification number: C07D471/04 , C07D401/12 , C07D401/14 , C07D407/14
Abstract: The disclosure concerns heterobicyclic compounds of general formula (I) and acid addition salts, hydrates and solvates thereof, as well as enantiomers, diastereoisomers and mixtures thereof. Methods for preparing the compounds, pharmaceutical compositions, and methods of treatment also are disclosed.
Abstract translation: 本公开涉及通式(I)的杂双环化合物及其酸加成盐,水合物和溶剂合物,以及对映异构体,非对映异构体及其混合物。 还公开了制备化合物的方法,药物组合物和治疗方法。
-
26.Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same 有权
Title translation: 吡啶并[2,3-d]嘧啶的衍生物及其制备方法及其治疗应用公开(公告)号:US08008310B2
公开(公告)日:2011-08-30
申请号:US12362656
申请日:2009-01-30
Applicant: Bernard Bourrie , Pierre Casellas , Samir Jegham , Claude Muneaux , Pierre Perreaut
Inventor: Bernard Bourrie , Pierre Casellas , Samir Jegham , Claude Muneaux , Pierre Perreaut
IPC: C07D471/04 , A61K31/519 , A61P35/00
CPC classification number: C07D471/04
Abstract: Derivatives of pyrido[2,3-d]pyrimidine are provided having formula (I) with Ar1, Ar2 and R1 as defined herein, which are useful for treating cell proliferative conditions, and to the preparation thereof, and to the therapeutic application of the same.
Abstract translation: 提供吡啶并[2,3-d]嘧啶的衍生物,其具有如本文所定义的具有本文定义的Ar1,Ar2和R1的式(I),其可用于治疗细胞增殖状况及其制备,以及治疗应用 相同。
-
27.2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof 失效
Title translation: 2-酰基氨基-4-苯基噻唑衍生物,其制备及其治疗应用公开(公告)号:US07504511B2
公开(公告)日:2009-03-17
申请号:US11253998
申请日:2005-10-19
Applicant: Pierre Carayon , Pierre Casellas , Daniel Floutard , Pierre Fraisse , Samir Jegham , Bernard Labeeuw
Inventor: Pierre Carayon , Pierre Casellas , Daniel Floutard , Pierre Fraisse , Samir Jegham , Bernard Labeeuw
IPC: C07D211/68 , C07D277/00 , A61K31/425
CPC classification number: C07D401/04 , C07D277/46 , C07D405/12 , C07D417/12 , C07D417/14 , C07D471/10 , C07D487/08
Abstract: The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
Abstract translation: 本发明涉及通式(I)的2-酰基氨基-4-苯基噻唑衍生物:其药学上可接受的酸加成盐,该衍生物的水合物或溶剂合物或其药学上可接受的酸加成盐,其中间体,其制备方法, 及其治疗应用。
-
28.Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors 审中-公开
Title translation: 新型2,4-Dianilinopyrimidine衍生物,其制备方法,用作药物,药物组合物,特别是作为IKK抑制剂公开(公告)号:US20080269170A1
公开(公告)日:2008-10-30
申请号:US11971389
申请日:2008-01-09
Applicant: Michael Bosch , Monsif Bouaboula , Pierre Casellas , Samir Jegham , Serge Mignani , Jean-Flaubert Nguefack , Jacob-Alsboek Olsen , Bernard Tonnerre , Jean Wagnon
Inventor: Michael Bosch , Monsif Bouaboula , Pierre Casellas , Samir Jegham , Serge Mignani , Jean-Flaubert Nguefack , Jacob-Alsboek Olsen , Bernard Tonnerre , Jean Wagnon
IPC: C07D403/02 , C07D401/02 , A61K31/397 , A61K31/506 , A61K31/505 , A61P3/10 , A61P37/00 , A61P35/00
CPC classification number: C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/08 , C07D471/14 , C07F9/65583
Abstract: The disclosure relates to compounds of formula (I): wherein R1-R5, A and Y are as defined in the disclosure, to compositions comprising said compounds, and to processes for making and methods of using the same.
Abstract translation: 本公开涉及式(I)化合物:其中R1-R5,A和Y如本公开所定义,包含所述化合物的组合物,以及其制备方法和使用该化合物的方法。
-
29.Derivatives of Pyrido[2,3-d]pyrimidine, the Preparation Thereof, and the Therapeutic Application of the Same 有权
Title translation: 吡啶并[2,3-d]嘧啶衍生物及其制备方法及其治疗应用公开(公告)号:US20080176874A1
公开(公告)日:2008-07-24
申请号:US11955583
申请日:2007-12-13
Applicant: Bernard BOURRIE , Pierre CASELLAS , Samir JEGHAM , Claude MUNEAUX , Pierre PERREAUT
Inventor: Bernard BOURRIE , Pierre CASELLAS , Samir JEGHAM , Claude MUNEAUX , Pierre PERREAUT
IPC: A61K31/519 , C07D471/04 , A61P35/00
CPC classification number: C07D471/04
Abstract: The invention relates to derivatives of pyrido[2,3-d]pyrimidine, to the preparation thereof, and to the therapeutic application of the same.
Abstract translation: 本发明涉及吡啶并[2,3-d]嘧啶的衍生物及其制备方法及其治疗应用。
-
30.Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics 有权
Title translation: 吡啶并吲哚酮衍生物在3-位被苯基取代,其制备及其在治疗中的应用公开(公告)号:US07390818B2
公开(公告)日:2008-06-24
申请号:US11109068
申请日:2005-04-19
Applicant: Bernard Bourrie , Pierre Casellas , Paola Ciapetti , Jean-Marie Derocq , Samir Jegham , Yvette Muneaux , Camille-Georges Wermuth
Inventor: Bernard Bourrie , Pierre Casellas , Paola Ciapetti , Jean-Marie Derocq , Samir Jegham , Yvette Muneaux , Camille-Georges Wermuth
IPC: A61K31/437 , C07D471/04
CPC classification number: C07D471/04
Abstract: The present invention relates to pyridoindolone derivatives substituted in the 3-position by a phenyl of general formula (I): to processes for preparing the same and to their use in therapeutics.
Abstract translation: 本发明涉及通过通式(I)的苯基在3-位上取代的吡啶并吲哚酮衍生物:其制备方法及其在治疗中的用途。
-
-
-
-
-
-
-
-
-